LINC01865

Across TCGA pan-cancer cohorts, LINC01865 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01865 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher LINC01865 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01865 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.

KICH, UVM, and BRCA are the cancer types where LINC01865 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.901	0.970	.003	90	view →
UVM	DFS	Tertile	II,III,IV	0.310	0.614	.007	72	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
LUAD	DFS	Tertile	All	0.867	0.768	.003	36	view →
READ	OS	Tertile	III,IV	0.718	0.915	.010	27	view →
ACC	OS	Quartile	III,IV	0.490	0.901	.014	26	view →
DLBC	OS	Quartile	All	0.509	0.919	.028	15	view →
THYM	DFS	Tertile	All	0.360	0.811	.002	12	view →
SARC	DFS	Median	All	0.241	0.458	.009	8	view →
GBM	DFS	Median	All	0.157	0.246	.008	6	view →
KIRC	DFS	Median	III,IV	0.571	0.713	.022	6	view →
CHOL	OS	Quartile	All	0.168	0.672	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01865–KICH (OS)

Open the KICH breakdown →